Funds Holding Celgene Corporation

 
Fund Quotes for Funds Holding Celgene Corporation top ^
  • Holdings: Gilead Sciences Inc , Celgene Corp , Vertex Pharmaceuticals Inc , Alexion Pharmaceuticals Inc , Regeneron Pharmaceuticals Inc ,
  • Category: Health
  • Morningstar Rating: 4 Stars
Sign-up for fbtcx investment picks
  • Holdings: Gilead Sciences Inc , Celgene Corp , Vertex Pharmaceuticals Inc , Alexion Pharmaceuticals Inc , Regeneron Pharmaceuticals Inc ,
  • Category: Health
  • Morningstar Rating: 4 Stars
Sign-up for fbttx investment picks
  • Holdings: Gilead Sciences Inc , Vertex Pharmaceuticals Inc , Celgene Corp , Alexion Pharmaceuticals Inc , Regeneron Pharmaceuticals Inc ,
  • Category: Health
  • Morningstar Rating: 5 Stars
Sign-up for fbiox investment picks
  • Holdings: Gilead Sciences Inc , Amgen Inc , AbbVie Inc , Biogen Idec Inc , Celgene Corp ,
  • Category: Trading-Leveraged Equity
Sign-up for bipsx investment picks
  • Holdings: Boulder Total Return Common , Tri-Continental Corporation Common , Celgene Corp , EMC Corp , FMC Corporation ,
  • Category: Large Blend
  • Morningstar Rating: 1 Stars
Sign-up for anqcx investment picks
  • Holdings: Boulder Total Return Common , Tri-Continental Corporation Common , Celgene Corp , EMC Corp , FMC Corporation ,
  • Category: Large Blend
  • Morningstar Rating: 1 Stars
Sign-up for ANQCX investment picks

 
News Articles for Celgene Corporation top ^
Celgene Corporation (NASDAQ: CELG) will host a conference call and live audio webcast on Thursday, October 23, 2014 at 9 a.m. ET to discuss third quarter 2014 financial and operational results.
Sign-up for Celgene Corporation to Announce Third Quarter 2014 Results on October 23, 2014 investment picks
Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor conferences, where Celgene management will provide an overview of the Company, and at the 56th American Society of Hematology (ASH) annual meeting in December.
Sign-up for Celgene Corporation to Webcast at Upcoming Investor Conferences and Medical Congress investment picks
Celgene Corporation (NASDAQ:CELG) received notice of an unsolicited “mini-tender” offer by TRC Capital Corporation to purchase up to 1,000,000 shares of Celgene’s common stock, approximately 0.13% of outstanding shares, at $101.75 per share.
Sign-up for Celgene Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Corporation investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Funds Holding Celgene Corporation
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Celestica, Inc.  |  Next: Funds Holding Celldex Therapeutics, Inc.